<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/119C5534-C0BC-4310-8481-C7E06B395A08"><gtr:id>119C5534-C0BC-4310-8481-C7E06B395A08</gtr:id><gtr:name>General Electric (GE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B5877968-9894-4490-A8ED-983A3DDA1DC6"><gtr:id>B5877968-9894-4490-A8ED-983A3DDA1DC6</gtr:id><gtr:name>Farr Institute of Health Informatics Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1529F791-0B6A-40F4-B05C-510DCB0DF8CB"><gtr:id>1529F791-0B6A-40F4-B05C-510DCB0DF8CB</gtr:id><gtr:name>Angioma Alliance</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E2174C7-CECC-4A37-9ED0-C16D5B6A585B"><gtr:id>4E2174C7-CECC-4A37-9ED0-C16D5B6A585B</gtr:id><gtr:name>NHS England</gtr:name><gtr:address><gtr:line1>NHS South of England</gtr:line1><gtr:line2>NHS Commissioning Board</gtr:line2><gtr:line3>PO Box 16728</gtr:line3><gtr:postCode>B97 9PT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75450506-2C1F-43CF-9CC3-329FB463511B"><gtr:id>75450506-2C1F-43CF-9CC3-329FB463511B</gtr:id><gtr:name>Erasmus University Rotterdam (EUR)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/36EF56FC-959A-4505-900B-8AC24663707A"><gtr:id>36EF56FC-959A-4505-900B-8AC24663707A</gtr:id><gtr:name>Dutch Cerebral Amyloid Angiopathy Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5C83B169-ED97-4A9C-8A39-033B5A151D0F"><gtr:id>5C83B169-ED97-4A9C-8A39-033B5A151D0F</gtr:id><gtr:name>University Hospital of Lille</gtr:name><gtr:address><gtr:line1>2, avenue Oscar Lambre</gtr:line1><gtr:postCode>F-59037</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A9F99648-1CE6-4CB7-B161-5713336BE374"><gtr:id>A9F99648-1CE6-4CB7-B161-5713336BE374</gtr:id><gtr:name>George Institute for Global Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/119C5534-C0BC-4310-8481-C7E06B395A08"><gtr:id>119C5534-C0BC-4310-8481-C7E06B395A08</gtr:id><gtr:name>General Electric (GE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B5877968-9894-4490-A8ED-983A3DDA1DC6"><gtr:id>B5877968-9894-4490-A8ED-983A3DDA1DC6</gtr:id><gtr:name>Farr Institute of Health Informatics Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1529F791-0B6A-40F4-B05C-510DCB0DF8CB"><gtr:id>1529F791-0B6A-40F4-B05C-510DCB0DF8CB</gtr:id><gtr:name>Angioma Alliance</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E2174C7-CECC-4A37-9ED0-C16D5B6A585B"><gtr:id>4E2174C7-CECC-4A37-9ED0-C16D5B6A585B</gtr:id><gtr:name>NHS England</gtr:name><gtr:address><gtr:line1>NHS South of England</gtr:line1><gtr:line2>NHS Commissioning Board</gtr:line2><gtr:line3>PO Box 16728</gtr:line3><gtr:postCode>B97 9PT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75450506-2C1F-43CF-9CC3-329FB463511B"><gtr:id>75450506-2C1F-43CF-9CC3-329FB463511B</gtr:id><gtr:name>Erasmus University Rotterdam (EUR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/36EF56FC-959A-4505-900B-8AC24663707A"><gtr:id>36EF56FC-959A-4505-900B-8AC24663707A</gtr:id><gtr:name>Dutch Cerebral Amyloid Angiopathy Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5C83B169-ED97-4A9C-8A39-033B5A151D0F"><gtr:id>5C83B169-ED97-4A9C-8A39-033B5A151D0F</gtr:id><gtr:name>University Hospital of Lille</gtr:name><gtr:address><gtr:line1>2, avenue Oscar Lambre</gtr:line1><gtr:postCode>F-59037</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A9F99648-1CE6-4CB7-B161-5713336BE374"><gtr:id>A9F99648-1CE6-4CB7-B161-5713336BE374</gtr:id><gtr:name>George Institute for Global Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/259AEBBF-4114-4CD4-B664-2BD42596F907"><gtr:id>259AEBBF-4114-4CD4-B664-2BD42596F907</gtr:id><gtr:firstName>Rustam</gtr:firstName><gtr:otherNames>Al-Shahi</gtr:otherNames><gtr:surname>Salman</gtr:surname><gtr:orcidId>0000-0002-2108-9222</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1002605"><gtr:id>408EA06C-C049-49A3-A2D3-BCD888BB70DE</gtr:id><gtr:title>Cerebral amyloid angiopathy and intracerebral haemorrhage: community-based cohort study, biobank, and record linkage</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1002605</gtr:grantReference><gtr:abstractText>This research is about cerebral amyloid angiopathy, which is known as ?CAA? for short. In CAA, a protein gradually damages blood vessels in the brain. CAA can be found in elderly people who are healthy, who have dementia, or who have stroke due to brain haemorrhage.
This research aims to find out how CAA causes brain haemorrhages, how to recognise CAA in people with brain haemorrhage before they die, and what predicts whether someone who survives brain haemorrhage might have another one.
The research will: (1) recruit adults with brain haemorrhage in one community, (2) obtain consent to collect information about them, their brain scans and their brain tissue, (3) compare them to people without brain haemorrhage in another MRC study, (4) compare different types of brain haemorrhage to eachother, and (5) study the outcome after different types of brain haemorrhage in one country.
This research might benefit patients by finding out why brain haemorrhage happens, how to recognise its cause, and who is most likely to have it again. This could help identify ways of preventing brain haemorrhage in future, which will become more common as the population ages. Studying ageing is one of the MRC?s two research priorities.</gtr:abstractText><gtr:technicalSummary>Background: Spontaneous intracerebral haemorrhage (ICH) affects ~1.5 million adults in the world each year. Unlike ischaemic stroke, the incidence of ICH is not declining and does not have specific treatments. Most ICH occurs in people aged ?70 years, and ICH incidence is likely to rise in ageing societies. Deposition of amyloid in cerebral vessel walls, known as cerebral amyloid angiopathy (CAA), is more common with age and in people with dementia. CAA is often inferred to be the cause of ICH in the brain?s lobes, but the strength of the association between CAA and lobar ICH, the causal pathway(s), accuracy of diagnostic criteria for ICH due to CAA, and best preventive strategies are unclear.
Aim: To better understand how CAA causes ICH, develop diagnostic criteria to identify patients who have CAA underlying ICH, and determine factors influencing prognosis. This stratified medicine approach will inform the design of secondary prevention trials. The objective is to promote healthy ageing (an MRC research priority theme).
Design: Community-based ICH biobank, nested within a population-based study.
Methods:
(1) Using multiple, overlapping sources of case ascertainment I will find incident cases of ICH in a community-based cohort study, and create a biobank of clinical and radiographic data and brain tissue (44% consented to donation so far). I will investigate the association between CAA and lobar ICH in case-control comparisons with the community-based MRC Cognitive Function and Ageing Study (CFAS). I will determine the accuracy of different diagnostic criteria for CAA associated with lobar ICH in my community-based ICH study, using blinded comparisons of clinical criteria, imaging, and cerebrospinal fluid biomarkers to an autopsy reference standard.
(2) I will establish two novel record linkages, from a Scottish population-based ICH dataset to national prescribing data and digital brain images, to perform multivariable analyses of clinical, imaging, and thereutic influences on prognosis after ICH. Estimates of treatment effect and potential recruitment rates will help design trials to improve ICH outcome.
Scientific and medical opportunities:
 Unique ability to link population-wide clinical, brain imaging and prescribing data.
 Efficient and cost-effective methods using existing NHS data and international collaborations.
 Expertise in my institution in stroke medicine, brain banking, brain imaging, epidemiological methods, trials methodology research, and nurturing and training clinical academics.
 Promising recruitment and tissue donation rates to my community-based ICH biobank.
 Data and tissue collected will enable me to take a stratified approach to deep ICH.</gtr:technicalSummary><gtr:fund><gtr:end>2017-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1684279</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Farr Institute of Health Informatics Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Partnership with the Farr Institute</gtr:description><gtr:id>10C7A2F7-33BF-4050-ACFD-ECB0C6B0C8F1</gtr:id><gtr:impact>A prototype of the tool has been used recently in a collaboration, automating the collection of imaging for an identified cohort, which previously had been a labour intensive manual process. The imaging of the cohort will be used to investigate the development an automated software application that will identify stroke.

Regulatory approvals for this process to happen in NHS Lothian.

This work has supported a funding applications to the British Heart Foundation. Also this tool, or the knowledge gained developing it will support a service currently being developed by the Farr@Scotland, which will be used by funded research projects.

An oral presentation titled &amp;quot;Establishing the 'Missing Linkage' with Imaging in Scottish Health Data: A Pilot for Intracerebral Haemorrhage&amp;quot; was given at The Farr Institute International Conference 2015.

A basic software tool has been developed which will be improved by a continuing development program. The knowledge gained during the tool development has provide information that has contributed to the provision of a research PACS at the Farr@Scotland.</gtr:impact><gtr:outcomeId>56dffd9ad33860.35076884-1</gtr:outcomeId><gtr:partnerContribution>Information governance and architecture</gtr:partnerContribution><gtr:piContribution>Intellectual design of a system for routinely obtaining imaging from the National Picture Archiving Communications System (PACS) of NHS Scotland</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Rotterdam</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Epidemiology</gtr:department><gtr:description>External advisory board to EDAN</gtr:description><gtr:id>25E15E68-2AC8-493C-A5B2-CC2033A03EFC</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>cohRppAdc4F-2</gtr:outcomeId><gtr:partnerContribution>Instigators of this collaboration</gtr:partnerContribution><gtr:piContribution>Invited to join external advisory board of the Early Detection of Alzheimer's Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>George Institute for Global Health</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Neurological and Mental Health Division</gtr:department><gtr:description>Collaboration with George Institute for Global Health</gtr:description><gtr:id>28210660-6A94-4B3B-9B41-3140D5BECF65</gtr:id><gtr:impact>I have been awarded a British Heart Foundation travel fellowship to pursue this collaboration.</gtr:impact><gtr:outcomeId>cywtUHtbST3-1</gtr:outcomeId><gtr:partnerContribution>Added factorial arm to my randomised controlled trial and pursued funding from the NH&amp;amp;MRC in Australia.</gtr:partnerContribution><gtr:piContribution>Designed randomised controlled trial.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>International Stroke Genetics Consortium</gtr:department><gtr:description>Collaboration with the International Stroke Genetics Consortium</gtr:description><gtr:id>77DB9830-3333-4738-B90C-F4BC1B9E9181</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>58c5be97b777d7.12829975-1</gtr:outcomeId><gtr:partnerContribution>Analysis of SNPs and statistical analysis.</gtr:partnerContribution><gtr:piContribution>Contribution of DNA for GWAS analyses.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Research Ethics Service</gtr:department><gtr:description>Health Research Authority</gtr:description><gtr:id>19C30A49-60BB-411A-ABFB-5A4A4FFE8299</gtr:id><gtr:impact>Research study underway</gtr:impact><gtr:outcomeId>hYo9S1TXXKG-1</gtr:outcomeId><gtr:partnerContribution>The partner governs this activity in the UK.</gtr:partnerContribution><gtr:piContribution>Design of research studies to improve the efficiency and minimise waste in the assessment of applications to research ethics committees.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>Collaboration with the Oxford Vascular Study</gtr:description><gtr:id>008F98DE-8227-41E9-BCD8-F435FF03BC15</gtr:id><gtr:impact>Publication in Brain, Pub Med ID 19042932</gtr:impact><gtr:outcomeId>9F450E964AF-1</gtr:outcomeId><gtr:partnerContribution>Joint analysis of our two cohorts, resulting in a publication in Brain</gtr:partnerContribution><gtr:piContribution>We led on the data analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Center for Cerebrovascular Research</gtr:department><gtr:description>UCSF Center for Cerebrovascular Research</gtr:description><gtr:id>BB65F9FA-4611-4467-960C-5E519644404E</gtr:id><gtr:impact>Applying to NIH as co-PI for funding of a randomised trial</gtr:impact><gtr:outcomeId>rm4JBj87zwN-1</gtr:outcomeId><gtr:piContribution>Intellectual contribution to design of a randomised controlled trial</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lille University Hospital</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Collaboration with Lille haemorrhagic stroke group</gtr:description><gtr:id>F1DC024D-466C-4E6A-B986-8621A90AE6E0</gtr:id><gtr:impact>Several publications</gtr:impact><gtr:outcomeId>mt6UHSBQzAR-1</gtr:outcomeId><gtr:partnerContribution>Several publications using shared data</gtr:partnerContribution><gtr:piContribution>Supervision of a postgraduate student, sharing data, leading on analyses</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Collaboration with Institute of Neurology</gtr:description><gtr:id>2126EBCA-3C90-48B0-ACCD-01DCAB0B7FEF</gtr:id><gtr:impact>Co-applicant on successful programme grant application to the BHF</gtr:impact><gtr:outcomeId>SmpTMhYHwMc-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on current studies and obtaining funding for future research studies,</gtr:partnerContribution><gtr:piContribution>Intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dutch Cerebral Amyloid Angiopathy Foundation</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Scientific Advisory Board for the CAA Foundation</gtr:description><gtr:id>2DBC24B7-7158-4F4D-8018-A571B69F6B2A</gtr:id><gtr:impact>Priority Setting Partnership initiated</gtr:impact><gtr:outcomeId>54561f3b868b31.02687242-1</gtr:outcomeId><gtr:partnerContribution>They initiated it.</gtr:partnerContribution><gtr:piContribution>Developing a research agenda for the condition in collaboration with patients and carers</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Collaboration with Nottingham University</gtr:description><gtr:id>794F7E44-3254-4541-ACD0-90A98C1BFCFC</gtr:id><gtr:impact>NIHR HTA successful grant application</gtr:impact><gtr:outcomeId>TPCD14Nt5Kq-1</gtr:outcomeId><gtr:partnerContribution>Lead on trial grant application</gtr:partnerContribution><gtr:piContribution>Member of Trial Steering Committee and NIHR HTA project grant co-applicant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Neurobiology</gtr:department><gtr:description>Collaboration with Boston Haemorrhagic Stroke Research Programme</gtr:description><gtr:id>03DFA40C-0A16-4FAF-827E-8109D5BBFDE6</gtr:id><gtr:impact>MRC senior clinical fellowship application</gtr:impact><gtr:outcomeId>eQrT5zKVowX-1</gtr:outcomeId><gtr:partnerContribution>Their collaboration has underpinned the development of my senior clinical fellowship application to MRC</gtr:partnerContribution><gtr:piContribution>I have generated the hypotheses, and designed the research programme</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Collaboration with Amsterdam Medical Centre</gtr:description><gtr:id>F6C125B5-C5F4-4DDB-A4E3-0DF2C18358ED</gtr:id><gtr:impact>Ongoing trial</gtr:impact><gtr:outcomeId>QFKVdYPzfp7-1</gtr:outcomeId><gtr:partnerContribution>Initiation of randomised controlled trial.</gtr:partnerContribution><gtr:piContribution>Intellectual input into clinical trial conduct and recruitment of patients.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>General Electric (GE)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neurosciences; GE Healthcare</gtr:department><gtr:description>Investigator sponsored study with GE Healthcare</gtr:description><gtr:id>D1D90691-3814-4E16-AEF9-5E214D829BF0</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56dffc5a5aa662.66374361-1</gtr:outcomeId><gtr:partnerContribution>Provision of radiotracer and funding for PET scans</gtr:partnerContribution><gtr:piContribution>Intellectual design of protocol.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Angioma Alliance</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>USA Angioma Alliance Scientific Advisory Board</gtr:description><gtr:id>0CE18EA8-9E11-4A1A-913D-A51A38E79A13</gtr:id><gtr:impact>Publication of guidelines for the definition of haemorrhage from cerebral cavernous malformations</gtr:impact><gtr:outcomeId>54562243004e13.39860115-1</gtr:outcomeId><gtr:partnerContribution>Access to network of researchers and opportunity to create consensus guidelines</gtr:partnerContribution><gtr:piContribution>Advice on scientific strategy. Authoring of guidance documents</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Public Health and Primary Care</gtr:department><gtr:description>Collaboration with the MRC Cognitive Function and Ageing Study</gtr:description><gtr:id>20BF963D-A15F-4AD8-B2AE-32A5779EE28C</gtr:id><gtr:impact>None so far</gtr:impact><gtr:outcomeId>DMjwmFb8zFY-1</gtr:outcomeId><gtr:partnerContribution>It is a globally unique comparison group for one of my research projects</gtr:partnerContribution><gtr:piContribution>I have designed the study that we will do in collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Hemorrhagic Stroke Research Programme</gtr:department><gtr:description>External advisory board to EDAN</gtr:description><gtr:id>E96BA44A-DDFE-486C-A161-F7153C67FF33</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>cohRppAdc4F-1</gtr:outcomeId><gtr:partnerContribution>Instigators of this collaboration</gtr:partnerContribution><gtr:piContribution>Invited to join external advisory board of the Early Detection of Alzheimer's Network</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>External advisory board to EDAN</gtr:description><gtr:id>E6F7B9D2-2F75-453B-82D8-E0C9B715AD60</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>cohRppAdc4F-3</gtr:outcomeId><gtr:partnerContribution>Instigators of this collaboration</gtr:partnerContribution><gtr:piContribution>Invited to join external advisory board of the Early Detection of Alzheimer's Network</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>PATCH collaboration with AMC</gtr:description><gtr:id>45CBA66D-01DB-4CCA-8FAE-8054E1ADF9B3</gtr:id><gtr:impact>Successful Chest Heart &amp;amp; Stroke Scotland project grant application</gtr:impact><gtr:outcomeId>eP812SKBURt-1</gtr:outcomeId><gtr:partnerContribution>Lead on randomised controlled trial</gtr:partnerContribution><gtr:piContribution>Membership of trial steering committee</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Edinburgh Clinical Research Methodology Course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>75123A9A-8DD6-45CA-8F86-1E82D0A30D0D</gtr:id><gtr:impact>I co-organised this two-day clinical research methodology course, which attracted major international talent and 150 delegates.

Enhanced education of peers, helping advance career progression.</gtr:impact><gtr:outcomeId>j94a4D8WTQ7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ecat.ed.ac.uk/research-methods/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk on the Lancet Increasing Value and Reducing Waste series at the Florey Institute in Melbourne, Australia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>23D2215E-32B1-43BD-9EF5-38982CA4ADEB</gtr:id><gtr:impact>Conveyed recommendations from the Lancet Increasing Value and Reducing Waste series

Institutional recommendations made for Increasing Value and Reducing Waste</gtr:impact><gtr:outcomeId>54569055e84af2.97568133</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk on management of intracranial vascular malformations</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>24DC9396-F9C4-4B99-A6E6-66E67585BC2F</gtr:id><gtr:impact>40 doctors attended my talk, which influenced their management of patients

I was invited to participate in an American Heart Association guidelines panel</gtr:impact><gtr:outcomeId>5456507683d4f3.03958632</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Reference Group meetings</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FFDC4819-373F-4453-90FB-BD6D10BD6E57</gtr:id><gtr:impact>When designing my sub-study, I involved a group of patient representatives (the RUSH Patient Reference Group (RUSH PRG)). The RUSH PRG is comprised of 3 stroke survivors, 2 women and 1 man, 2 of which have had an intracerebral haemhorrhage. They provided valuable assistance in the development of the study materials and have reviewed and commented upon the information sheet and consent forms for LINCHPIN COG.

We try to meet with the group once a year, where we keep them up-to-date with all ongoing projects and discuss any issues that arise in the undertaking of these studies.</gtr:impact><gtr:outcomeId>56d5c677ea8449.04123443</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Stroke Day talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CC306B7A-BDE0-4245-B43F-DEB7D21623D2</gtr:id><gtr:impact>Talk about the importance of lowering blood pressure to prevent stroke, as part of the Global Health Academy event on World Stroke Day.</gtr:impact><gtr:outcomeId>56e092675eb8f5.84786310</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ed.ac.uk/global-health/news-events/events/past-events/global-story-of-strokes</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Stroke Day public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>329327FE-2081-4AEA-942F-6D7429A6313B</gtr:id><gtr:impact>Lecture to the public on World Stroke Day</gtr:impact><gtr:outcomeId>56b7c0b7a81629.28330814</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Biobank stroke outcomes working group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2C19E72B-8BAB-4CD6-AB4E-ABE6C386CA59</gtr:id><gtr:impact>To determine how to identify strokes that occur amongst UK Biobank participants

Changed approach to coding stroke in UK Biobank</gtr:impact><gtr:outcomeId>gLzMXW3V3Q1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research to Understand Stroke due to Haemorrhage (RUSH) website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C9BD2440-48C6-40C3-9FDA-6E412784449F</gtr:id><gtr:impact>Website describing the work of my whole programme of research

Information for patients and charitable donations as a result</gtr:impact><gtr:outcomeId>mErQyfbaSkf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.rush.ed.ac.uk</gtr:url><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast for The Lancet Neurology about a research output</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1131343C-F6CC-46CE-AE18-354E73B2D630</gtr:id><gtr:impact>12-minute podcast about the findings of my paper in The Lancet Neurology, directly relevant to patient care.</gtr:impact><gtr:outcomeId>56e091887877c4.71010518</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.thelancet.com/laneur/audio</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>1st Congress of the European Academy of Neurology, Berlin, Germany</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CEC939C6-2F14-49A3-8C4B-27EFD7BFC147</gtr:id><gtr:impact>Invited speaker at teaching course: 1st Congress of the European Academy of Neurology, Berlin, Germany</gtr:impact><gtr:outcomeId>56e09e328f6d82.54253562</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Irish Institute of Clinical Neuroscience meeting, Londonderry</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>69215B54-48DE-4774-A6B0-E58BF504847E</gtr:id><gtr:impact>Invited to speak at Irish Institute of Clinical Neuroscience meeting, Londonderry</gtr:impact><gtr:outcomeId>56e0a0b8e3f076.77487720</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk to the Cairns Society of Adelaide on incidental findings on brain imaging</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>920E32C2-3872-4C01-B874-7457D17B7D5E</gtr:id><gtr:impact>Presentation of my research work with implications for practice.

Colleagues' education</gtr:impact><gtr:outcomeId>54568fc67ff9c8.96961399</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release about article in The Lancet Neurology</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>45B7E216-5FA6-4CC2-9E80-0E2BF1EA7C1C</gtr:id><gtr:impact>People at risk of a bleed in their brain will be helped by a study that has calculated the likelihood of bleeding occurring.</gtr:impact><gtr:outcomeId>56e08fccd3f078.81219870</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ed.ac.uk/news/2015/cavernoma-021215</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Advanced Clinical Neurology Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>36476CC3-39AA-4924-8F21-38797718DC1E</gtr:id><gtr:impact>70 neurologists attended my talk to learn about whether a recently described condition is a real diagnostic entity or not.

Approached by a prospective clinical research fellow.</gtr:impact><gtr:outcomeId>54569303282598.41487993</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh International Science Festival talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>06BC8ABE-F958-439E-9E5E-5F5F1865B793</gtr:id><gtr:impact>A growing trend toward MRI brain scanning is revealing a lot more than beautiful images of healthy brains. But how do neurologists decide when treatment is required and would we all benefit from a brain scanning programme? Join MRC Senior Clinical Fellow and Consultant Neurologist Rustam Al-Shahi Salman for a discussion on the issues as he reveals just how abnormal many of our normal brains really are.

Audience of over 100 people stimulated by talk, provoking questions from 7 to 70 year-olds!</gtr:impact><gtr:outcomeId>oe2C85SwSMm</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.co.uk/whats-on/categories/talk/picturing-your-brain</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Neurosurgery department, Essen, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>64F400E2-FDC2-47CD-8A38-1332AE3C6B92</gtr:id><gtr:impact>Discussion of the design of a randomised controlled trial that could be run in Germany</gtr:impact><gtr:outcomeId>58c71205c15ff9.37071980</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Hubs for Trial Methodology Research, Trial Recruitment Working Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B8900017-E70A-4007-8531-B48FB4408CD6</gtr:id><gtr:impact>I am a member of the MRC Hubs for Trial Methodology Research, Trial Recruitment Working Group, focussing on ways to improve recruitment to trials.</gtr:impact><gtr:outcomeId>56e08ee23e61a0.22570463</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Written information leaflets for patient support organisations</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>150AE88A-AF3E-49A3-B3C0-1CC1C53C7332</gtr:id><gtr:impact>The first patient information leaflets for patients in the UK with this condition

Patients better informed. Grants awarded from the patient support organisation to underpin further similar activities</gtr:impact><gtr:outcomeId>P969MJ5Avv8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stroke Research Network: 'Patient, Carer &amp; Public Involvement Day'</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6378CCCE-CC4D-441B-B64B-62A79F9A4CA9</gtr:id><gtr:impact>The day was targeted at Patients, Carers &amp;amp; Public in and around Glasgow, and was an opportunity for attendees to learn more about stroke research and how they can become involved as a lay person. I had a table at this event where I spoke to attendees about the research that we are doing which sparked questions and discussions relating to some of the long-term impacts of stroke and how these have effected both the patients and their family.</gtr:impact><gtr:outcomeId>56d5ccdc8ee1f9.32163440</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stroke 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>766C4D62-345E-449C-8DB0-BAA2335F47EF</gtr:id><gtr:impact>Up-to-date information about managing stroke

Publicisation of best practice in managing brain haemorrhage, and opportunities to do research to improve future care</gtr:impact><gtr:outcomeId>DtJy7QjMnHf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.rcpsg.ac.uk/~/media/Files/Events/Stroke/Stroke_2013_Flyer_Single%20Pages.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Stroke Forum</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8EFA5F6E-3439-4EB6-8A13-6CE73CA03FE5</gtr:id><gtr:impact>Invited talk and ongoing trials stand at the UK Stroke Forum

Increase number of centres in RESTART and ultimately trial recruitment</gtr:impact><gtr:outcomeId>ELJ7PCYt2L2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.stroke.org.uk/professionals/uk-stroke-forum/uksf-conference</gtr:url><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2011 CCM workshop</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D95AFF9C-4933-4C05-918D-325747B6AE26</gtr:id><gtr:impact>Presentation of the first clinical guidelines for adults with cavernous malformations

Disseminated at Society of British Neurological Surgeons conference and prompted an invitation to speak at their subsequent meeting</gtr:impact><gtr:outcomeId>ZmceCuLenSm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;Senior career opportunites post CCT&quot; talk at Scottish Medical Education Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BDB46B37-C495-41CA-A564-C78F820C9A63</gtr:id><gtr:impact>&amp;quot;Senior career opportunites post CCT&amp;quot; talk at Scottish Medical Education Conference

Inspiring colleagues to pursue careers in academic medicine</gtr:impact><gtr:outcomeId>ETHvpZSyC7o</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.rcpsg.ac.uk/~/media/Files/News/3rd%20National%20Scottish%20Medical%20Education%20Conference/Programme_9.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to medicine of the elderly specialty trainees</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>272CB8F3-BE08-4D08-A1A5-8DDE1D2EB844</gtr:id><gtr:impact>Regional training day, to inspire trainees to conduct stroke research</gtr:impact><gtr:outcomeId>58c7149bebaad1.42397850</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Centre for Research into Evidence-Based Practice (Gold Coast, Australia) invited talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5400C06B-A93C-40AB-AA0F-73135F634C32</gtr:id><gtr:impact>3-day research visit and invited talk, to stimulate the next phase of my research programme and collaborative work.

I was asked to talk to a Melbourne newspaper for a feature article on my research</gtr:impact><gtr:outcomeId>54568dd0473335.25842957</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient focus group meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9529C77-B58E-4006-B245-F440A2EF66AB</gtr:id><gtr:impact>Patients provided feedback on design and materials for my research

Beneficial effect on content of information and favourable opinion from Research Ethics Committee</gtr:impact><gtr:outcomeId>gz2vLjcC3k6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Organised a session at the British Cardiovascular Society meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0F3491C8-12FE-4900-BD37-0B14A832D439</gtr:id><gtr:impact>BCS/British Association of Stroke Physicians
Thrombectomy for acute ischaemic stroke: a new role for the cardiologist?

Chairs
Prof Rustam Al-Shahi Salman
Prof Adrian Banning 

Talks 
Evidence for IV thrombolysis for acute ischaemic stroke Dr William Whiteley Biography 
Evidence for thrombectomy for acute ischaemic stroke Prof Keith Muir Biography 
Interventional neuroradiologists should deliver thrombectomy Prof Philip White 
Interventional cardiologists should deliver thrombectomy Dr Iqbal Malik 
Panel discussion</gtr:impact><gtr:outcomeId>58c71b853203f8.86553522</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.bcs.com/ProgrammeSessions/session_details.asp?SessionID=3454949</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Stroke Day public engagement information stand in my hospital</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A7779BB2-6479-46C7-9510-32338743D719</gtr:id><gtr:impact>Information stand about my research and information about the condition that it focuses on, for World Stroke Day.

One hundred people had their blood pressure checked and several required treatment with antihypertensive drugs for primary prevention.</gtr:impact><gtr:outcomeId>5456954eee5ee3.55463656</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RESTART website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3BF8683B-CEBA-4AD5-8155-D86745C20116</gtr:id><gtr:impact>RESTART trial website

Information for the public and patients about this trial</gtr:impact><gtr:outcomeId>DuYX5fVyquT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.RESTARTtrial.org</gtr:url><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participant newsletters</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A79154B3-F571-4735-9D15-75BE89606DB0</gtr:id><gtr:impact>Annual newsletters to participants

Improved participant satisfaction</gtr:impact><gtr:outcomeId>7DC7B86ABBA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to Sheffield neuroscience department</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A31FA300-A101-41D6-A81C-6C66AACF2132</gtr:id><gtr:impact>Invited lecture to neuroscience department</gtr:impact><gtr:outcomeId>58c713ca5036d9.77338843</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentations to patient organisations</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4F3B9899-0CD5-46FE-AEF6-5A300A7B31B1</gtr:id><gtr:impact>Patient education and information

Charitable funding (&amp;pound;20,000) was raised for the patient organisation as a result of my involvement.</gtr:impact><gtr:outcomeId>19084E9D04B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk on the Lancet Increasing Value and Reducing Waste series at the Centre for Kidney Research, Westmead Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4D494E18-6E4D-41F6-AADD-AAA6A2D909B7</gtr:id><gtr:impact>Institutional response to The Lancet series

I was asked to talk to the New South Wales Director of Health about how they could reform research regulation</gtr:impact><gtr:outcomeId>54568f38729819.85207838</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to the Edinburgh Stroke Winter School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1058CC49-A013-4788-B8A6-7FFB0A13FB4C</gtr:id><gtr:impact>Talk on the pros and cons of observational research to aspiring academic clinicians.

Two clinical research fellows were recruited to my department.</gtr:impact><gtr:outcomeId>54565145690823.98282158</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ed.ac.uk/schools-departments/clinical-brain-sciences/postgraduate-training/edinburgh-stroke-winter-school</gtr:url><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research to Understand Stroke due to Haemorrhage (RUSH) Patient Reference Group</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>35FB3C1E-1958-4D2A-9814-06D580EAA30D</gtr:id><gtr:impact>Information about my patient reference group, who provide input on all of our research activities</gtr:impact><gtr:outcomeId>58c71716440849.38837102</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.ed.ac.uk/clinical-brain-sciences/research/diagnoses-disease-targets/rush/rush-patient-reference-group</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of the Working Group on Thrombosis of the European Society of Cardiology</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>11A1BCE4-E2EC-4634-8EB7-C81D366C5B97</gtr:id><gtr:impact>Member of the Working Group on Thrombosis of the European Society of Cardiology, producing a position paper on, &amp;quot;Bleeding prevention and antithrombotic strategies after bleeding in patients with coronary artery disease&amp;quot;</gtr:impact><gtr:outcomeId>56e08f305b6275.99822611</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk at Regional Neuroscience Centre, University Hospital Wales, Cardiff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4A4C9534-CFF3-46BE-A690-875DF059FC5D</gtr:id><gtr:impact>Invited to talk about recent research outputs at Regional Neuroscience Centre, University Hospital Wales, Cardiff</gtr:impact><gtr:outcomeId>56e0a077541ae7.96527075</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BMJ Masterclass in Stroke</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5497DA2B-AC2E-4887-9E76-32BA0B3BACE2</gtr:id><gtr:impact>Sell out audience of 120 consultants and trainees at BMJ Masterclass in Stroke in London. I was rated the top speaker.

Publicisation of best practice in managing brain haemorrhage, and opportunities to do research to improve future care. Subsequent contact from budding stroke researchers and questions about clinical management.</gtr:impact><gtr:outcomeId>KEXrDSDCCrB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://masterclasses.bmj.com</gtr:url><gtr:year>2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>1st World AVM conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D806845A-420C-493B-B269-04A05A7815B8</gtr:id><gtr:impact>I co-organised the first ever world AVM congress attended by 300 doctors from all over the world

Greater awareness of neurological issues for patients</gtr:impact><gtr:outcomeId>JXDiphAfj31</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>@BleedingStroke Twitter feed</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6E018628-85BD-4B00-8DA4-EDFEBF268F66</gtr:id><gtr:impact>Hundreds of people follow my Twitter feed about matters relating to stroke due to haemorrhage</gtr:impact><gtr:outcomeId>56e090840b40b0.48800965</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://twitter.com/BleedingStroke</gtr:url><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Stroke Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>776DEB2B-A4B8-410C-B997-237D70C6C877</gtr:id><gtr:impact>Invited speaker - Promotion of my research outputs and ongoing randomised controlled trial to &amp;gt;1,000 international delegates

More hospitals joined the RESTART randomised controlled trial</gtr:impact><gtr:outcomeId>Rt8LViZvF1d</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.eso-stroke.org/eso-stroke/esoc-meetings.html</gtr:url><gtr:year>2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Edinburgh Stroke Winter School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5B07D1A3-EA36-49A1-B3CE-29B2A5410B10</gtr:id><gtr:impact>Talk to would-be research fellows on &amp;quot;Intracranial haemorrhage: challenges and answerable questions&amp;quot;, to inspire them to seek funding to answer these questions</gtr:impact><gtr:outcomeId>58c712a94eb739.71764385</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ed.ac.uk/clinical-brain-sciences/postgraduate-training/edinburgh-stroke-winter-school</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>155000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Research Training Fellowship</gtr:department><gtr:description>Edinburgh Clinical Academic Track clinical research training fellowship</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3D795903-2293-417F-8E0E-A07C237C9D0F</gtr:id><gtr:outcomeId>56dfff563cd135.31103283</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Part-funding for a research-dedicated 3 Tesla Magnetic Resonance (MR) Scanner</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>The Dunhill Medical Trust</gtr:fundingOrg><gtr:fundingRef>R380R/1114</gtr:fundingRef><gtr:id>E8EFFA7A-67CA-4731-AE83-3C48CCCDFFE5</gtr:id><gtr:outcomeId>56b7bd010c2d11.00768533</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4950</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>INSPIRE: The intercalated degree: in a nutshell</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>18A0EFC8-2802-4DA1-AE50-2B4ADF728498</gtr:id><gtr:outcomeId>56b7bab5248299.72527445</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2504823</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Tranexamic acid for hyperacute primary Intracerebral Haemorrhage (TICH-2)</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>11/129/109</gtr:fundingRef><gtr:id>5D57F161-C392-4130-9C3A-FE659D04C6F6</gtr:id><gtr:outcomeId>Tm9jUZeVVpH</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81011</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept scheme</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:fundingRef>MRC/CIC2/015</gtr:fundingRef><gtr:id>001A9F68-D2AF-418E-B3C5-20FF529458DE</gtr:id><gtr:outcomeId>58c5bff209b063.52372519</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5311292</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)</gtr:description><gtr:end>2021-06-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:fundingRef>APP1103886</gtr:fundingRef><gtr:id>248FE609-2010-4E29-9396-78DEE704C1C2</gtr:id><gtr:outcomeId>56b7bbc121c583.57177617</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9250</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>INSPIRE</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>5710E2B9-DB6E-4613-B712-10EA41D56226</gtr:id><gtr:outcomeId>WSuZJp8KFcv</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251525</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Role of 18F-Fluoride imaging as a novel marker of plaque instability</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/12/8/29371</gtr:fundingRef><gtr:id>29C2DD5E-BC88-4393-ABDF-F25E9712A340</gtr:id><gtr:outcomeId>d3ivrnANLPm</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Biomedical Resource / Multi-User Equipment / Technology Development Grant</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>8B7C808D-FAFA-4901-AD22-80D28A749420</gtr:id><gtr:outcomeId>56b7bcad8cb604.64644082</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>National Health and Medical Research Council project grant</gtr:description><gtr:end>2021-06-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:fundingRef>APP1103886</gtr:fundingRef><gtr:id>20A93A75-7ECF-4EC9-BA4F-56103A781621</gtr:id><gtr:outcomeId>58c5c1fbec7096.55249421</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>155069</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer's Research UK Global Clinical Trials Fund</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>6BBBA303-BC1A-402F-B8B7-B40F2FCF4DE2</gtr:id><gtr:outcomeId>58c5c06b2aa631.34807584</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>51000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>18F-Flutemetamol for the ante mortem recognition of intracerebral haemorrhage due to cerebral amyloid angiopathy</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>GE Healthcare</gtr:fundingOrg><gtr:id>17A3F576-4615-495F-9C99-6776E17B1806</gtr:id><gtr:outcomeId>56b7ba5f989e37.34271860</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>105000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stroke Association postgraduate fellowship (Katie McGoohan)</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Stroke Association</gtr:fundingOrg><gtr:fundingRef>TSA Postgrad 2014/02</gtr:fundingRef><gtr:id>B3A7FA13-405F-4083-8610-1E2207CFA9F2</gtr:id><gtr:outcomeId>545629854e4851.91796609</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>448144</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Prevention Of Hypertensive Injury to the Brain by Intensive Treatment after IntraCerebral Haemorrhage (PROHIBIT ICH): a pilot randomized trial of home telemetry-guided treatment</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Stroke Association</gtr:fundingOrg><gtr:fundingRef>PPA2015/04</gtr:fundingRef><gtr:id>10B0A944-8CB6-4A2A-A50F-89865BB061ED</gtr:id><gtr:outcomeId>56b7bc416b1530.39388183</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>202356</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC / Stroke Association clinical training fellowship (Neshika Samarasekera)</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900428</gtr:fundingRef><gtr:id>07C7F937-7C2D-4A8C-9047-977C2EC58FE0</gtr:id><gtr:outcomeId>54562a12a09b09.40737878</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>298962</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRI evaluation of effects of tranexamic acid in spontaneous intracerebral haemorrhage: The TICH-2 MRI study</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/14/96/31262</gtr:fundingRef><gtr:id>B904EC01-BCDC-4B61-8AE8-7877F894F188</gtr:id><gtr:outcomeId>56b7bd8552a768.86014472</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Appointment to American Heart Association guidelines committee for arteriovenous malformations of the brain</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>132B40DD-B9BE-409E-B6CC-47AD08F874F1</gtr:id><gtr:impact>Authorship of guidelines that will discourage the use of treatments that I showed in a recent clinical trial and population-based cohort to cause a three-fold increase in the risk of stroke in comparison to no treatment.</gtr:impact><gtr:outcomeId>54565c2f03ffe9.99237329</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BASP scientific committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F05248CE-F3EA-46C5-8714-95A0FFD4C3CC</gtr:id><gtr:impact>Educational activities for UK stroke physicians and neurologists</gtr:impact><gtr:outcomeId>e7rr2Rjvs9L</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>AVM review cited by BMJ Best Practice</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Cerebral arteriovenous malformation</gtr:guidelineTitle><gtr:id>C4C08E9C-7F1A-419B-9712-33F27F8B054F</gtr:id><gtr:impact>Effective use of diagnostic and therapeutic techniques for brain arteriovenous malformations</gtr:impact><gtr:outcomeId>Wiu4FQxuoba</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cavernoma management guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9510FD4D-3D62-439A-B865-63A5B4AF667A</gtr:id><gtr:impact>These are the first ever guidelines for the management of adults with cerebral cavernous malformations</gtr:impact><gtr:outcomeId>aokmDDa7vnS</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.cavernoma.org.uk/opus452.html</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage</gtr:guidelineTitle><gtr:id>C837AB6C-B979-4338-96F0-5E0521D2B219</gtr:id><gtr:impact>Importance of avoidance of haemostatic drugs in spontaneous ICH not associated with antithrombotic drug use</gtr:impact><gtr:outcomeId>54565b33f2cba1.54628407</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European guidelines on intracerebral haemorrhage</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7EEE741E-C34B-4E07-9DA9-EDE0146A1354</gtr:id><gtr:impact>Guidance to practitioners based on the best available evidence in clinical trials.</gtr:impact><gtr:outcomeId>JKcarULuCES</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://onlinelibrary.wiley.com/store/10.1111/ijs.12309/asset/ijs12309.pdf?v=1&amp;t=i20li2eq&amp;s=ec8a26db9809ef59b6b77088271fb22fc20eac80</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Neurological Surveillance Unit</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>125B9255-ABF2-4E2A-B3D6-C10DA36C810F</gtr:id><gtr:outcomeId>0E026E289DA</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Stroke Research Network Prevention Clinical Studies Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7A2A6921-239F-470F-B787-D447933982E0</gtr:id><gtr:impact>I was elected to the UK Stroke Research Network Prevention Clinical Studies Group to influence which research projects should be conducted in the UK</gtr:impact><gtr:outcomeId>L49Dqm6YiL6</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Academy of Medical Sciences INSPIRE lead for Edinburgh</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>88C00168-AE98-415F-AC43-2008C47DF65D</gtr:id><gtr:impact>I run this scheme to promote the involvement of medical students in research</gtr:impact><gtr:outcomeId>WA5Wv93MjqK</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in International League Against Epilepsy guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Cavernoma-related epilepsy: Review and recommendations for management - Report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies</gtr:guidelineTitle><gtr:id>8937F9BC-11AD-4529-B17A-023AAABB973E</gtr:id><gtr:impact>The risk of epilepsy after a first seizure relating to a cavernous malformation is so high that anti-epileptic drugs should be started without waiting for the second seizure</gtr:impact><gtr:outcomeId>k1sVPz9SYBp</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Committee for Standards in Haematology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>Guidelines for the use of platelet transfusions</gtr:guidelineTitle><gtr:id>03CD98BE-C2EF-4E19-ADCC-1E4FE8356645</gtr:id><gtr:impact>Avoidance of the use of platelet transfusion, which was shown to be harmful in this randomised trial</gtr:impact><gtr:outcomeId>58c7201511e523.39567352</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://onlinelibrary.wiley.com/doi/10.1111/bjh.14423/full</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Chest Heart and Stroke Scotland funding obtained for a pilot trial of oral anticoagulants after stroke due to intracerebral haemorrhage.</gtr:description><gtr:id>1A56EB78-2F14-423D-8E9B-ED520BF695ED</gtr:id><gtr:impact>International collaboration to address this therapeutic dilemma.</gtr:impact><gtr:outcomeId>56e099ee1a0567.53036661</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>RESTART-2 trial</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2015</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>REstart or STop Antithrombotics Randomised Trial (RESTART), a BHF-funded RCT to assess whether patients with intracerebral haemorrhage should continue or stop antithrombotic drugs after spontaneous intracerebral haemorrhage</gtr:description><gtr:id>DCFEC258-D459-4442-8A3E-E3659D2F255C</gtr:id><gtr:impact>Pragmatic phase four RCT which will influence practice</gtr:impact><gtr:outcomeId>kuBqXjPbwWg</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>RESTART trial</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:ukcrnIsctnId>ISRCTN71907627</gtr:ukcrnIsctnId><gtr:url>http://www.RESTARTtrial.org</gtr:url><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>We have used the data from our community based inception cohort study to create an online simulator of recruitment to randomised trials in this disease.</gtr:description><gtr:id>940497E2-47EC-4A19-B5AC-67277F988896</gtr:id><gtr:impact>Citation by other researchers and use of the simulator to design trials.</gtr:impact><gtr:outcomeId>56e0991d847422.44655321</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Intracerebral haemorrhage trial simulator</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.dcn.ed.ac.uk/ichsimulator/</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>It has been estimated that 85% of research is wasted, usually because it asks the wrong questions, is badly designed, not published or poorly reported. This diminishes the value of research and also represents a significant financial loss. However, many causes of this waste are simple problems that could easily be fixed, such as appropriate randomisation or blinding of a clinical trial. A first step towards increasing the value of research and reducing waste is to monitor the problems and develop solutions that aim to fix them: the REWARD Alliance does exactly that.</gtr:description><gtr:id>05E30D49-8104-4DE3-AD54-8F96CEAA65EC</gtr:id><gtr:impact>First REWARD Alliance conference, held jointly with the EQUATOR Network, in Edinburgh in September 2015.</gtr:impact><gtr:outcomeId>56e098592ebbc9.65559216</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Creation of the REduce research Waste And Reward Diligence (REWARD) Alliance and Lancet REWARD campaign</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://rewardalliance.net/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Community-based study of adults with intracerebral haemorrhage</gtr:description><gtr:id>959B4080-F1C5-4115-8DED-B299BFBCA7E0</gtr:id><gtr:impact>Collaboration with MRC Cognitive Function and Ageing Study in place for unique future analyses</gtr:impact><gtr:outcomeId>VCJjkBnqBu2</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Biobank of data, imaging, and tissue from patients with intracerebral haemorrhage</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>This website is intended to help researchers designing studies of adults with spontaneous (non-traumatic) intracerebral haemorrhage (ICH), particularly randomised controlled trials of treatments. The website provides estimates of the proportion of patients with ICH who might be eligible for a trial, based on chosen selection criteria. The simulator will help assess the impact of eligibility criteria on the generalisability and feasibility of a trial.</gtr:description><gtr:id>A91D6513-3A6B-467A-9BCB-54BBFDEE166D</gtr:id><gtr:impact>Improved design and inclusiveness of clinical trials into intracerebral haemorrhage</gtr:impact><gtr:outcomeId>545655cd1b1cb5.28589529</gtr:outcomeId><gtr:title>Intracerebral haemorrhage trial simulator</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://www.dcn.ed.ac.uk/ICHsimulator/</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FCBBB13F-E245-44B8-A85C-D9D762C71512</gtr:id><gtr:title>The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>X7317tpEswv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E92EE7B-AF48-4AC8-B62D-FE11BD9A20C6</gtr:id><gtr:title>Outcome markers for clinical trials in cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5f1e11b86ec0689918d02280094d1a"><gtr:id>ec5f1e11b86ec0689918d02280094d1a</gtr:id><gtr:otherNames>Greenberg SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>54561bd9e3f4b7.02055902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5774B876-EF71-4516-AD28-8ACD32FE4F8E</gtr:id><gtr:title>Stroke unit care benefits patients with intracerebral hemorrhage: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2b67f3bbf5bcc914d9b8243127ff768"><gtr:id>b2b67f3bbf5bcc914d9b8243127ff768</gtr:id><gtr:otherNames>Langhorne P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_12571_21_24065713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5AA43A9-AC2F-4B66-937B-4F653CDD6730</gtr:id><gtr:title>Intracranial Vascular Malformations and Epilepsy.</gtr:title><gtr:parentPublicationTitle>Seminars in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-8235</gtr:issn><gtr:outcomeId>56b7b7cc891202.98407407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>767ADFBA-8052-4842-BB62-D48151152259</gtr:id><gtr:title>Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db42d1cfaf0a5fe581d96d1e71804ae3"><gtr:id>db42d1cfaf0a5fe581d96d1e71804ae3</gtr:id><gtr:otherNames>Horne MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56dff604758506.98909287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2224147B-B833-4450-9C38-CF6199BED550</gtr:id><gtr:title>Intracerebral hemorrhage location and outcome among INTERACT2 participants.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c96a0856a7734636ffc6fc243b485e9b"><gtr:id>c96a0856a7734636ffc6fc243b485e9b</gtr:id><gtr:otherNames>Delcourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c4355630e779.13704403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D21A5714-1C8D-4913-B279-8E2C8D77F027</gtr:id><gtr:title>Association between diabetes mellitus and the occurrence and outcome of intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/725ecfdbee3bbe7df2511d2ac9502b14"><gtr:id>725ecfdbee3bbe7df2511d2ac9502b14</gtr:id><gtr:otherNames>Boulanger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>585d6a394c51d7.99407642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5856CF12-7E9D-42BE-88B5-3BB606F884E7</gtr:id><gtr:title>Top ten research priorities for brain and spine cavernous malformations</gtr:title><gtr:parentPublicationTitle>LANCET NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900ed6ab3beef196773fd6cff638785b"><gtr:id>900ed6ab3beef196773fd6cff638785b</gtr:id><gtr:otherNames>Salman Rustam Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5a3602c96c0c17.23978255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAFD332C-380E-42E2-9536-4FC79D09D4BB</gtr:id><gtr:title>Conservative management vs intervention for unruptured brain arteriovenous malformations--reply.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>54561bdbab9912.72087840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA864E7F-BBEE-4E3C-8AC7-9775F4C43882</gtr:id><gtr:title>Significance of Hematoma Shape and Density in Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial Study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c96a0856a7734636ffc6fc243b485e9b"><gtr:id>c96a0856a7734636ffc6fc243b485e9b</gtr:id><gtr:otherNames>Delcourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>58c437795a4c43.61685301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE1C5663-9787-4F27-95E7-64FC332E88C0</gtr:id><gtr:title>Antithrombotic Treatment After Stroke Because Of Intracerebral Hemorrhage</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c934e101ca4b7e7f2e6f5a30536d47e6"><gtr:id>c934e101ca4b7e7f2e6f5a30536d47e6</gtr:id><gtr:otherNames>Perry L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa44d6780d0c0.85478795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DD86D1A-567B-4001-A581-4110340622C6</gtr:id><gtr:title>European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aff88f0b872ddcb9447fb172425aa2bd"><gtr:id>aff88f0b872ddcb9447fb172425aa2bd</gtr:id><gtr:otherNames>Steiner T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>54561bdb5e95f7.41138034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03D9F548-5858-4780-8DEC-77327869D064</gtr:id><gtr:title>Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe1ae7eec9282fce441e9f9901826554"><gtr:id>fe1ae7eec9282fce441e9f9901826554</gtr:id><gtr:otherNames>Sprigg N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>58c437798f6970.84351853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78FFFC31-F822-43CB-9EBE-271B1828DC76</gtr:id><gtr:title>Top ten research priorities for brain and spine cavernous malformations.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58c43779b38307.90808507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A09B7896-2FB7-4DC9-8E50-0C469A448839</gtr:id><gtr:title>Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f14904fc5e4f067f329560931b39cd9"><gtr:id>0f14904fc5e4f067f329560931b39cd9</gtr:id><gtr:otherNames>Parry-Jones AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56b7b7cce92100.26509041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A39514F-1760-43E9-8874-2EEAC937DC16</gtr:id><gtr:title>Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_12571_21_22297119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54EB2AE6-9051-4D0C-BC34-E14964B51F34</gtr:id><gtr:title>Comparative studies of the diagnosis and treatment of cerebral cavernous malformations in adults: systematic review.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de514460dfbacbeeeb7a0c0549905857"><gtr:id>de514460dfbacbeeeb7a0c0549905857</gtr:id><gtr:otherNames>Poorthuis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn><gtr:outcomeId>pm_12571_21_23371401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BC06536-242E-4625-BE06-5D1A84E7AB27</gtr:id><gtr:title>Consent for Brain Tissue Donation after Intracerebral Haemorrhage: A Community-Based Study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675eaac3bfc8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E67335FB-2BD2-491F-8446-4D2A70FCC18E</gtr:id><gtr:title>Computed Tomographic Angiography or Magnetic Resonance Angiography for Detection of Intracranial Vascular Malformations in Patients With Intracerebral Hemorrhage</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e035c2b527e04d6157cafb7d0806ff9"><gtr:id>0e035c2b527e04d6157cafb7d0806ff9</gtr:id><gtr:otherNames>Josephson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5aa44d691056b2.03026138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10C6B5DE-69AC-4092-A48F-5A00213037C9</gtr:id><gtr:title>The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials.</gtr:title><gtr:parentPublicationTitle>Current drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b90fcb86f8ff0ef88ec4421190f7ff22"><gtr:id>b90fcb86f8ff0ef88ec4421190f7ff22</gtr:id><gtr:otherNames>Ross J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1574-8863</gtr:issn><gtr:outcomeId>pm_12571_21_22663958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CF0556C-FD51-4BE8-825A-B8B480591DE1</gtr:id><gtr:title>Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64570b4d0fe7032b5370bc611a6576c7"><gtr:id>64570b4d0fe7032b5370bc611a6576c7</gtr:id><gtr:otherNames>Pasquini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>54561bdb38d993.57770944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E5EB6D6-AC64-41B6-AFF6-6D7A89733715</gtr:id><gtr:title>Promoting Recruitment using Information Management Efficiently (PRIME): a stepped wedge SWAT (study-within-a-trial)</gtr:title><gtr:parentPublicationTitle>TRIALS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bd184756d29a13e993f1dcd34598e40"><gtr:id>3bd184756d29a13e993f1dcd34598e40</gtr:id><gtr:otherNames>Salman R. Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a35038582b214.63607101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94EAA31B-1AF0-4E46-B6E2-4397C8692014</gtr:id><gtr:title>Clinical prediction algorithm (BRAIN) to determine risk of hematoma growth in acute intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d33cf2ec743344310cadecc6294d895"><gtr:id>8d33cf2ec743344310cadecc6294d895</gtr:id><gtr:otherNames>Wang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56b7b7cdee9306.40781127</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC69A9B7-20EB-4584-A4AE-2581447D308D</gtr:id><gtr:title>The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5aa582239b84a9.46713443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DB4E998-7007-44FB-9E40-EFF418E2313A</gtr:id><gtr:title>Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: community-based study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1be6ad48864ef22d5f6d665d19f9d8d"><gtr:id>e1be6ad48864ef22d5f6d665d19f9d8d</gtr:id><gtr:otherNames>Fonville AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>541749ef0848a7.11286393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>419FAC4B-6623-466B-A447-95EFA06C7B3B</gtr:id><gtr:title>Management of brain arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54561bda409ed8.93825463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE752302-9B5E-4156-8402-AC9F6827E81C</gtr:id><gtr:title>Research: increasing value, reducing waste - Authors' reply.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1c0554fa8e8dfc389a47ed93c374c26"><gtr:id>c1c0554fa8e8dfc389a47ed93c374c26</gtr:id><gtr:otherNames>Glasziou P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54561bda199969.83181861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>989BE18A-05D8-440F-98D4-66CD32C6DD01</gtr:id><gtr:title>Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5e111e6e7df082c288a36bcdd75c869"><gtr:id>f5e111e6e7df082c288a36bcdd75c869</gtr:id><gtr:otherNames>Maxwell AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a350061b16138.10048747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D9FDFE0-4DED-4FD2-87C9-EFB0236F1806</gtr:id><gtr:title>There is still hope for surgery for spontaneous supratentorial intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_12571_21_22511012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A66499E-F456-4BF0-92D1-CFD235A79FEF</gtr:id><gtr:title>Genetic variants in CETP increase risk of intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f954a01e509b147c22aa4f0b693a321b"><gtr:id>f954a01e509b147c22aa4f0b693a321b</gtr:id><gtr:otherNames>Anderson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c43556dcc7f8.39391059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96791C30-8DEC-4E1B-9E55-4515C2527763</gtr:id><gtr:title>Treatment of cerebral cavernous malformations: a systematic review and meta-regression analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abf51cb12a6636f924cd773d527dc2c8"><gtr:id>abf51cb12a6636f924cd773d527dc2c8</gtr:id><gtr:otherNames>Poorthuis MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>54174c1f192817.59473536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08044ABF-91A5-430C-8B66-39912AFE9138</gtr:id><gtr:title>Evaluation of excess significance bias in animal studies of neurological diseases.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/152b16a02def31f110d90fe64c93d499"><gtr:id>152b16a02def31f110d90fe64c93d499</gtr:id><gtr:otherNames>Tsilidis KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>pm_12571_21_23874156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>579B7237-1811-4EE4-B35E-70497609C224</gtr:id><gtr:title>Promoting Recruitment using Information Management Efficiently (PRIME): statistical analysis plan for a stepped wedge cluster randomised trial within the REstart or STop Antithrombotics Randomised Trial (RESTART).</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/816b2c0d337ca5a556ce47648a35751a"><gtr:id>816b2c0d337ca5a556ce47648a35751a</gtr:id><gtr:otherNames>Parker RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>58c43555c79719.53101618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F82D8E3-F7DA-4D87-BF21-50D24B1F55A9</gtr:id><gtr:title>Association between diabetes mellitus and incidence of intracerebral haemorrhage and case fatality rates: A retrospective population-based cohort study.</gtr:title><gtr:parentPublicationTitle>Diabetes, obesity &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/725ecfdbee3bbe7df2511d2ac9502b14"><gtr:id>725ecfdbee3bbe7df2511d2ac9502b14</gtr:id><gtr:otherNames>Boulanger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1462-8902</gtr:issn><gtr:outcomeId>5a3612800b8592.50911112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BA7ECC6-8263-4116-B561-CA979F12B018</gtr:id><gtr:title>Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72a27611986100311fd3752b4f496d3d"><gtr:id>72a27611986100311fd3752b4f496d3d</gtr:id><gtr:otherNames>Sato S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56b7b7ca286e65.06235143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0172581-182E-40F8-8286-0F69C16BB228</gtr:id><gtr:title>Statistical analysis plan for the PlAtelet Transfusion in Cerebral Haemorrhage (PATCH) trial: a multicentre randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/733a5144245cb5843fc2d27daf7c603c"><gtr:id>733a5144245cb5843fc2d27daf7c603c</gtr:id><gtr:otherNames>Baharoglu MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>585d6a36589726.02679780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE6FBBE9-C3F2-4F18-BD41-4B8A43BA6916</gtr:id><gtr:title>Epidemiology of Intracerebral Haemorrhage.</gtr:title><gtr:parentPublicationTitle>Frontiers of neurology and neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72df702fceca6b67fe9a253042c28ef6"><gtr:id>72df702fceca6b67fe9a253042c28ef6</gtr:id><gtr:otherNames>Poon MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5186</gtr:issn><gtr:outcomeId>56b7b7cb307377.38012700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38144A88-4700-41B8-9C24-E074633DCFAB</gtr:id><gtr:title>The next step in understanding the prognosis of cerebral cavernous malformations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12571_21_22302544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0515503-155F-4CFF-9759-1B11AC49140B</gtr:id><gtr:title>Promoting Recruitment using Information Management Efficiently (PRIME): a stepped-wedge, cluster randomised trial of a complex recruitment intervention embedded within the REstart or Stop Antithrombotics Randomised Trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5e111e6e7df082c288a36bcdd75c869"><gtr:id>f5e111e6e7df082c288a36bcdd75c869</gtr:id><gtr:otherNames>Maxwell AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a639473a34ac2.45579469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F74C15E1-204B-48F6-AB01-D5FAE7E818B0</gtr:id><gtr:title>Methods to improve patient recruitment and retention in stroke trials.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/889459a7ee599cec60bedb06624900f0"><gtr:id>889459a7ee599cec60bedb06624900f0</gtr:id><gtr:otherNames>Berge E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>58c4355730a314.15421221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0504ABD-8149-4C91-8648-DBF1FA2D6586</gtr:id><gtr:title>Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5f39df0424a95c379004f509d0428af"><gtr:id>d5f39df0424a95c379004f509d0428af</gtr:id><gtr:otherNames>Dineen RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5aa58222c0dbb4.93401154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D44114CC-A041-48EB-9B45-6D365D46951E</gtr:id><gtr:title>Quality of life and disability 12 months after surgery vs. conservative management for unruptured brain arteriovenous malformations: Scottish population-based and Australian hospital-based studies.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6ce24dad099922574199e57404e6520"><gtr:id>b6ce24dad099922574199e57404e6520</gtr:id><gtr:otherNames>O'Donnell JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn><gtr:outcomeId>5aa44d66dcc0d5.94710718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB66D3DE-E1E7-4A15-8A86-68DB12E57B1C</gtr:id><gtr:title>Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72df702fceca6b67fe9a253042c28ef6"><gtr:id>72df702fceca6b67fe9a253042c28ef6</gtr:id><gtr:otherNames>Poon MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>54174aeb660151.60783213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8F50075-C632-4944-83CB-1B828825E1AD</gtr:id><gtr:title>Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b157ef3d628d3c5e49b6db6d66e6f56d"><gtr:id>b157ef3d628d3c5e49b6db6d66e6f56d</gtr:id><gtr:otherNames>Rannikm?e K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12571_21_23457231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E9CF965-48EF-404A-87D5-6139CF6BB7D6</gtr:id><gtr:title>Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/324b1e1df09141f985ccd5529c03abfd"><gtr:id>324b1e1df09141f985ccd5529c03abfd</gtr:id><gtr:otherNames>Dorhout Mees SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12571_21_22633825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CF84C17-3970-49EF-87CD-0402D51C159E</gtr:id><gtr:title>Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/850a850541a03fa726eef1599847c853"><gtr:id>850a850541a03fa726eef1599847c853</gtr:id><gtr:otherNames>Wilson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56b7b7caa623c5.29720678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAFD97EF-95F4-438B-9D68-361CEF258D04</gtr:id><gtr:title>Genome-wide association study of sporadic brain arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2a13fee4dd46dddbcbaca29dbc5d471"><gtr:id>a2a13fee4dd46dddbcbaca29dbc5d471</gtr:id><gtr:otherNames>Weinsheimer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56b7b7ca6f6c32.06600601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B8AED34-F342-4095-AE57-7F19A8066D83</gtr:id><gtr:title>Brain banking for neurological disorders.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_12571_21_24074724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>284EF757-DD35-49BE-B11B-CBDD120312BF</gtr:id><gtr:title>Reliability of intracerebral hemorrhage classification systems: A systematic review.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b157ef3d628d3c5e49b6db6d66e6f56d"><gtr:id>b157ef3d628d3c5e49b6db6d66e6f56d</gtr:id><gtr:otherNames>Rannikm?e K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>585d450ba92496.61354336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E96A65C-E330-4AD0-871F-BA11FB0F6868</gtr:id><gtr:title>Accuracy of Patient Self-Report of Stroke: A Systematic Review from the UK Biobank Stroke Outcomes Group.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc177bc67084e61937ac7f2b418f0334"><gtr:id>bc177bc67084e61937ac7f2b418f0334</gtr:id><gtr:otherNames>Woodfield R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa44d68df4253.79428894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33096BDB-6C86-46E2-ADB3-218446DE95AE</gtr:id><gtr:title>Regulation and governance of multinational drug trials in stroke: barriers and possibilities.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/889459a7ee599cec60bedb06624900f0"><gtr:id>889459a7ee599cec60bedb06624900f0</gtr:id><gtr:otherNames>Berge E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>56b7b7cd9fb444.16476567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E53AA011-B96E-414D-AE64-78FE8947FCAC</gtr:id><gtr:title>Biomedical research: increasing value, reducing waste</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1578040adfc0368ba5c1f3e6bafc5bd"><gtr:id>e1578040adfc0368ba5c1f3e6bafc5bd</gtr:id><gtr:otherNames>Macleod M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54174b46b26983.84168812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7BE923B-C194-496D-814D-AF429B9A763E</gtr:id><gtr:title>Outcome after surgical or conservative management of cerebral cavernous malformations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c1dbb5b22be0db92a6593a4bc58d4bb"><gtr:id>5c1dbb5b22be0db92a6593a4bc58d4bb</gtr:id><gtr:otherNames>Moultrie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54561bda97fea3.28581997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CF92B9A-8D40-49D8-9501-57600A22441A</gtr:id><gtr:title>Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies.</gtr:title><gtr:parentPublicationTitle>Cerebrovascular diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d33cf2ec743344310cadecc6294d895"><gtr:id>8d33cf2ec743344310cadecc6294d895</gtr:id><gtr:otherNames>Wang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-9770</gtr:issn><gtr:outcomeId>56b7b7cd2a36a8.84485662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>235B68DE-63DD-407F-9281-EC5BE9F5D4FE</gtr:id><gtr:title>Seizure risk with AVM treatment or conservative management: prospective, population-based study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12571_21_22764257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BF09FE6-C741-49A7-A680-187E726658E3</gtr:id><gtr:title>Antiplatelet therapy may be continued after intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>54561bdbd52e86.53848883</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>967A6DCC-B82A-4ED7-9EB7-CDA45BF2FE7F</gtr:id><gtr:title>Antithrombotic treatment after stroke due to intracerebral haemorrhage.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73c25e760cd6bf094b706383e2407b51"><gtr:id>73c25e760cd6bf094b706383e2407b51</gtr:id><gtr:otherNames>Perry LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>5aa44d67dd6e92.75180738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F5AC8A6-210A-4829-B9ED-CBF07FE2A0F5</gtr:id><gtr:title>Peer review: a flawed but essential process.</gtr:title><gtr:parentPublicationTitle>The journal of the Royal College of Physicians of Edinburgh</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dd5f863a232bfdbc85129a01e8dc8c2"><gtr:id>2dd5f863a232bfdbc85129a01e8dc8c2</gtr:id><gtr:otherNames>Iredale J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1478-2715</gtr:issn><gtr:outcomeId>pm_12571_21_23240111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B227063-5149-4BC6-8390-BA4F3421C4BF</gtr:id><gtr:title>Erratum to: Promoting Recruitment using Information Management Efficiently (PRIME): study protocol for a stepped-wedge cluster randomised controlled trial within the REstart or STop Antithrombotics Randomised Trial (RESTART).</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5e111e6e7df082c288a36bcdd75c869"><gtr:id>f5e111e6e7df082c288a36bcdd75c869</gtr:id><gtr:otherNames>Maxwell AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5aa5822369a4e8.71411920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D0CC73D-8052-4629-9961-70CD06513A50</gtr:id><gtr:title>-0589 CAROTID OCCLUSIVE DISEASE: THE NOTTINGHAM EXPERIENCE</gtr:title><gtr:parentPublicationTitle>INTERNATIONAL JOURNAL OF STROKE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0ffc8d1b98238df71a6cacc0e49b1c7"><gtr:id>b0ffc8d1b98238df71a6cacc0e49b1c7</gtr:id><gtr:otherNames>Maddula M.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>5a350325162b05.71911025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28A6998E-D873-4882-A707-AACD3D5E1A9D</gtr:id><gtr:title>Cochrane Database of Systematic Reviews - Reviews</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c934e101ca4b7e7f2e6f5a30536d47e6"><gtr:id>c934e101ca4b7e7f2e6f5a30536d47e6</gtr:id><gtr:otherNames>Perry L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:outcomeId>5aa44d68a422b4.50092852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5358D8CE-4AAE-4E29-8C3E-DEB560DEA699</gtr:id><gtr:title>Routinely collected data for randomized trials: promises, barriers, and implications.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04cdd27ff5f30933e96efc7883eed3af"><gtr:id>04cdd27ff5f30933e96efc7883eed3af</gtr:id><gtr:otherNames>Mc Cord KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5aa44d6712d2d2.68506616</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42ED89F5-AF19-4910-A08E-49A4DF571ABC</gtr:id><gtr:title>Deposition of amyloid ? in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6064a4d07cab171f38b6cdd1227ad29"><gtr:id>e6064a4d07cab171f38b6cdd1227ad29</gtr:id><gtr:otherNames>Keable A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56dff655d8f4c9.03466570</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DCB6B98-F94C-4B90-9BDF-0391E369D787</gtr:id><gtr:title>Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies.</gtr:title><gtr:parentPublicationTitle>Neuroepidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c8c78ef79a6c5af275104b65fc05b3d"><gtr:id>2c8c78ef79a6c5af275104b65fc05b3d</gtr:id><gtr:otherNames>Davis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0251-5350</gtr:issn><gtr:outcomeId>pm_12571_21_23075508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34FFC447-F15D-425B-A5F1-88B2F2133317</gtr:id><gtr:title>Dementia after stroke due to intracerebral haemorrhage.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5821dbbe75ee77.88114763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A31742DA-8CDC-4819-B41C-9B21CBE22B3F</gtr:id><gtr:title>Review and publication of protocol submissions to Trials - what have we learned in 10&amp;nbsp;years?</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e4c36d738780cdad30d8e39a6bcb764"><gtr:id>3e4c36d738780cdad30d8e39a6bcb764</gtr:id><gtr:otherNames>Li T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>58c435565cde44.30121433</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68E74BFC-820B-4028-B8A3-D4C1445FEDAA</gtr:id><gtr:title>Can an ethics officer role reduce delays in research ethics approval? A mixed-method evaluation of an improvement project.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c872a2b157f74c5544699e57d04805a"><gtr:id>5c872a2b157f74c5544699e57d04805a</gtr:id><gtr:otherNames>Dixon-Woods M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>58c435570fd346.41266159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>420E7F6B-4608-43E9-A400-C66EB5DCA390</gtr:id><gtr:title>Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30090b6ac8e7835f0dcaf37d05926960"><gtr:id>30090b6ac8e7835f0dcaf37d05926960</gtr:id><gtr:otherNames>Kim H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54561bdabddbf0.71611470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FD9206A-66C4-44E4-B09A-851144E403AE</gtr:id><gtr:title>Management of brain arteriovenous malformations</gtr:title><gtr:parentPublicationTitle>LANCET</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900ed6ab3beef196773fd6cff638785b"><gtr:id>900ed6ab3beef196773fd6cff638785b</gtr:id><gtr:otherNames>Salman Rustam Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5a3517d43c7b88.86997253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3725322-0DFA-43D3-A429-2F692E65DA58</gtr:id><gtr:title>Relative risk of hemorrhage during pregnancy in patients with brain arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49bfd50d3d2df0cefb65c8f203b6e56b"><gtr:id>49bfd50d3d2df0cefb65c8f203b6e56b</gtr:id><gtr:otherNames>van Beijnum J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>5aa44d687407e7.68347749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E0FACF3-FFAD-4AE3-9617-D547FAEB2D11</gtr:id><gtr:title>Intracerebral haemorrhage, atrial fibrillation, and anticoagulation.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/850a850541a03fa726eef1599847c853"><gtr:id>850a850541a03fa726eef1599847c853</gtr:id><gtr:otherNames>Wilson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56b7b7cb73a146.30041427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8D1A5EF-AC95-4541-9D01-D45E27E9A25A</gtr:id><gtr:title>Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0cd56c5d6f324ffe01776b7518642ba"><gtr:id>d0cd56c5d6f324ffe01776b7518642ba</gtr:id><gtr:otherNames>Xu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa582232a0643.79541619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8DCEE2E-D4DF-4CA3-975C-B3D6608BBBFE</gtr:id><gtr:title>Conservative Management vs Intervention for Unruptured Brain Arteriovenous Malformations Reply</gtr:title><gtr:parentPublicationTitle>JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900ed6ab3beef196773fd6cff638785b"><gtr:id>900ed6ab3beef196773fd6cff638785b</gtr:id><gtr:otherNames>Salman Rustam Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>5a3518bd1eeb21.30141680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D01493B-AD65-44F6-A41C-FD6C0F710B9A</gtr:id><gtr:title>Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Neurosurgical review</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0011eb27afb07d0b60324f83a09fbf6f"><gtr:id>0011eb27afb07d0b60324f83a09fbf6f</gtr:id><gtr:otherNames>Poon MTC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0344-5607</gtr:issn><gtr:outcomeId>5aa44d6808b349.49189942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4FFCA25-2E11-4FD3-A974-E31C17E09CF9</gtr:id><gtr:title>METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec4c2f252be2865b6012e13ad8992889"><gtr:id>ec4c2f252be2865b6012e13ad8992889</gtr:id><gtr:otherNames>METACOHORTS Consortium. Electronic address: joanna.wardlaw@ed.ac.uk</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>5aa44d68c389f9.71947489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66825A26-D1E4-4595-A110-70BF76CA0D17</gtr:id><gtr:title>The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ad5aecaf2a18378f9020b9030625195"><gtr:id>7ad5aecaf2a18378f9020b9030625195</gtr:id><gtr:otherNames>Etminan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56b7b7cc1ce855.79437474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38B7DFAF-CD26-4D58-9948-A910443C0867</gtr:id><gtr:title>Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56b7b7cd565526.41948141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6B089D3-739D-49C6-A471-914FAFABEE4E</gtr:id><gtr:title>The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6981c962662ff970fe9940bc30407e3"><gtr:id>d6981c962662ff970fe9940bc30407e3</gtr:id><gtr:otherNames>Charidimou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>56b7b7cc537f89.07774089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14B6DF1E-719A-42DF-B06B-70D73B3A6073</gtr:id><gtr:title>Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310a48a6d49f39ef71b7decfc3126e79"><gtr:id>310a48a6d49f39ef71b7decfc3126e79</gtr:id><gtr:otherNames>Mohr JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54174a9f882479.67359528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F69170D-82E4-4765-8723-51328CF58FD8</gtr:id><gtr:title>Characteristics of Randomized Trials Focusing on Stroke due to Intracerebral Hemorrhage: Systematic Review.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51bad2b5c6a0b635cb5625200f8322c3"><gtr:id>51bad2b5c6a0b635cb5625200f8322c3</gtr:id><gtr:otherNames>Tamborska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>5aa58223cfe1e7.96198508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8A3EC2C-CEA7-4143-B850-FA2AB0B09D0B</gtr:id><gtr:title>Prognosis and treatment of intracranial dural arteriovenous fistulae: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33342a95a5440ee213f0804af9129157"><gtr:id>33342a95a5440ee213f0804af9129157</gtr:id><gtr:otherNames>Kobayashi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>54561bdae1fd33.96304133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41E95612-3943-4112-80BB-E1B6335BB039</gtr:id><gtr:title>Dementia after stroke due to intracerebral haemorrhage</gtr:title><gtr:parentPublicationTitle>LANCET NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900ed6ab3beef196773fd6cff638785b"><gtr:id>900ed6ab3beef196773fd6cff638785b</gtr:id><gtr:otherNames>Salman Rustam Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5a3518732bb570.58413728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE52FAB8-FACC-4571-92DF-BC58301E440E</gtr:id><gtr:title>Discontinuation and non-publication of neurodegenerative disease trials: a cross-sectional analysis.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4132fea4d09960a24b77ca12e924b67e"><gtr:id>4132fea4d09960a24b77ca12e924b67e</gtr:id><gtr:otherNames>Stefaniak JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>5aa44d68509412.35071931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0032ACD9-10B6-4AA4-8B82-CDED31D85140</gtr:id><gtr:title>Promoting Recruitment using Information Management Efficiently (PRIME): study protocol for a stepped-wedge cluster randomised controlled trial within the REstart or STop Antithrombotics Randomised Trial (RESTART).</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5e111e6e7df082c288a36bcdd75c869"><gtr:id>f5e111e6e7df082c288a36bcdd75c869</gtr:id><gtr:otherNames>Maxwell AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>58c435560bcda0.45048497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EA5896D-F483-46BD-B970-D4026BECD6E9</gtr:id><gtr:title>Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fdf635b80e58069202486d2702398a2"><gtr:id>3fdf635b80e58069202486d2702398a2</gtr:id><gtr:otherNames>Halvorsen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>58c43556b4f011.09934307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE318DC2-75CC-4E37-B2FA-D1D4F1D65AC1</gtr:id><gtr:title>Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5f1e11b86ec0689918d02280094d1a"><gtr:id>ec5f1e11b86ec0689918d02280094d1a</gtr:id><gtr:otherNames>Greenberg SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>54561bda66ebf3.60761121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E26345C-8546-4AD8-AA68-94625A4F4543</gtr:id><gtr:title>Increasing value and reducing waste in biomedical research regulation and management.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54174bbadfd135.10648829</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54755238-1B59-4099-A6C5-7DF63B5E31F1</gtr:id><gtr:title>Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II).</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6770663bda38d5664fa7f399d4c2a67"><gtr:id>b6770663bda38d5664fa7f399d4c2a67</gtr:id><gtr:otherNames>Leijenaar JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>5aa44d692bbd55.01760778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>704C1CEF-A935-4F09-95DD-CDB74EAAB7CE</gtr:id><gtr:title>Early Magnesium Treatment After Aneurysmal Subarachnoid Hemorrhage: Individual Patient Data Meta-Analysis.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/324b1e1df09141f985ccd5529c03abfd"><gtr:id>324b1e1df09141f985ccd5529c03abfd</gtr:id><gtr:otherNames>Dorhout Mees SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56b7b7cbbf06a1.92261153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45F9A6AE-A727-418A-8CA7-568140FE8589</gtr:id><gtr:title>Strokes: mimics and chameleons.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4481ca1393b021ab022de27067a7e1d"><gtr:id>c4481ca1393b021ab022de27067a7e1d</gtr:id><gtr:otherNames>Fernandes PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>pm_12571_21_23315456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21B99C87-A7E5-4841-AF5D-BB6E60401549</gtr:id><gtr:title>The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16aed40476b29961e65b27fb8fcee6a7"><gtr:id>16aed40476b29961e65b27fb8fcee6a7</gtr:id><gtr:otherNames>Rodrigues M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aa44d67328466.68196315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B5D1F6E-15D1-4626-A127-FD11752729E4</gtr:id><gtr:title>APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b157ef3d628d3c5e49b6db6d66e6f56d"><gtr:id>b157ef3d628d3c5e49b6db6d66e6f56d</gtr:id><gtr:otherNames>Rannikm?e K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12571_21_24163429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CB97DE2-805E-4AE4-9A88-370F2BF84F68</gtr:id><gtr:title>Associations with health-related quality of life after intracerebral haemorrhage: pooled analysis of INTERACT studies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c96a0856a7734636ffc6fc243b485e9b"><gtr:id>c96a0856a7734636ffc6fc243b485e9b</gtr:id><gtr:otherNames>Delcourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58c4355696f3a3.18873968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA267CE0-3016-4824-9E68-989812098954</gtr:id><gtr:title>Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6981c962662ff970fe9940bc30407e3"><gtr:id>d6981c962662ff970fe9940bc30407e3</gtr:id><gtr:otherNames>Charidimou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5aa44d6826bd18.38644807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07F38C4E-DEED-41BC-AF22-929771CBDBAF</gtr:id><gtr:title>Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage.</gtr:title><gtr:parentPublicationTitle>Cerebrovascular diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72a27611986100311fd3752b4f496d3d"><gtr:id>72a27611986100311fd3752b4f496d3d</gtr:id><gtr:otherNames>Sato S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1015-9770</gtr:issn><gtr:outcomeId>56b7b7cae0e5b0.04651959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C4E0238-941A-400C-9E83-74FE7809BB03</gtr:id><gtr:title>Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6981c962662ff970fe9940bc30407e3"><gtr:id>d6981c962662ff970fe9940bc30407e3</gtr:id><gtr:otherNames>Charidimou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>5aa44d66aff255.07714028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CEAE167-BC0E-4FDD-A33D-41443185FC4D</gtr:id><gtr:title>Outcome after conservative management or intervention for unruptured brain arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_540e179e179260532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A5DAF4B-F2F0-4B6E-A4E6-BCD518E4FFEF</gtr:id><gtr:title>Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/733a5144245cb5843fc2d27daf7c603c"><gtr:id>733a5144245cb5843fc2d27daf7c603c</gtr:id><gtr:otherNames>Baharoglu MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>585d502545a9d4.72445714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7EA4034-E3FC-4B0C-A5A5-5F961EFC585E</gtr:id><gtr:title>CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd8c267b78cf5a764bc4ee22e4f0a1e"><gtr:id>cfd8c267b78cf5a764bc4ee22e4f0a1e</gtr:id><gtr:otherNames>Perel P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_12571_21_22417901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE38A6C4-30B4-4CDA-8FC4-ECEECBE2A3A2</gtr:id><gtr:title>F-Fluoride andF-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke: Case-Control Study.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe837d6e5b9c6f092137575a66757f43"><gtr:id>fe837d6e5b9c6f092137575a66757f43</gtr:id><gtr:otherNames>Vesey AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>5aa44d675b0188.37455090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEE9D831-6710-4866-9AA3-9A282C1A5A52</gtr:id><gtr:title>The European Stroke Organisation (ESO) guidelines.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aff88f0b872ddcb9447fb172425aa2bd"><gtr:id>aff88f0b872ddcb9447fb172425aa2bd</gtr:id><gtr:otherNames>Steiner T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>56b7b7ce2e49d5.72705861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F2A9AB4-6851-45D3-B4F1-945CD55A3907</gtr:id><gtr:title>Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>54561bdb843112.64969549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50A4BF96-6D2F-4195-A52A-1E5026478FD1</gtr:id><gtr:title>The outlook for adults with epileptic seizure(s) associated with cerebral cavernous malformations or arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>pm_12571_21_22946719</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002605</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>